Medindia
Medindia LOGIN REGISTER
Advertisement

Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results

Wednesday, November 7, 2007 General News
Advertisement
WAKEFIELD, MA, Nov. 6 /PRNewswire-FirstCall/ - NUCRYST PharmaceuticalsCorp. will hold a webcast at 4:30 p.m. EST on Wednesday, November 7, 2007regarding the company's 2007 third quarter results.
Advertisement

In addition to standard disclosure over wire services, a news release andfinancial statements will be posted on the NUCRYST web site. To listen to thecall live on the Internet, please go to www.nucryst.com.
Advertisement

Thomas E. Gardner, Chairman, President & CEO and Eliot M. Lurier, VicePresident, Finance & Administration and Chief Financial Officer willparticipate on the call.

An audio file of the call will be archived and posted on the NUCRYST website.

NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufacturesand commercializes medical products that fight infection and inflammationusing its patented atomically disordered nanocrystalline silver technology.Smith & Nephew plc sell a range of advanced wound care products under theirActicoat(TM) trade mark: Acticoat(TM) products incorporate NUCRYST'sSILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is alsodeveloping pharmaceutical products to address medical conditions that arecharacterized by both infection and inflammation. The Company has developedits proprietary nanocrystalline silver in a powder form for use as an activepharmaceutical ingredient, referred to as NPI 32101.

SILCRYST(TM) is a trademark of NUCRYST Pharmaceuticals Corp.

Acticoat(TM) is a trademark of Smith & Nephew plc

SOURCE NUCRYST Pharmaceuticals Corp.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close